Jeffrey L. Probstfield

29.0k citations

148 papers · 12.2k indexed · 6 hit papers · h-index 44

Cardiology and Cardiovascular Medicine top 0.2%
- Blood Pressure and Hypertension Studies 37
- Heart Failure Treatment and Management 23
- Cardiovascular Function and Risk Factors 15
Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes, Cardiovascular Risks, and Lipoproteins 14
- Diabetes Treatment and Management 13
Surgery top 0.5%
- Lipoproteins and Cardiovascular Health 23
Nutrition and Dietetics top 0.5%
Family Practice top 2%
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 16
Radiology, Nuclear Medicine and Imaging
- Cardiac Imaging and Diagnostics 12

Co-authors: Salim Yusuf David J. Gordon J. D. Knoke Herman A. Tyroler Shrikant I. Bangdiwala William P. Castelli James D. Neaton David R. Jacobs
Cited by: Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Surgery
Partner nations: United States Canada United Kingdom

In The Last Decade

Jeffrey L. Probstfield

146 papers receiving 11.6k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2011 Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events
2008 Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
2002 Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
1999 Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
1994 Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
1989 High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Peers

Countries citing papers authored by Jeffrey L. Probstfield

Since Specialization

Citations

This map shows the geographic impact of Jeffrey L. Probstfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Probstfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Probstfield more than expected).

Fields of papers citing papers by Jeffrey L. Probstfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Probstfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Probstfield. The network helps show where Jeffrey L. Probstfield may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jeffrey L. Probstfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeffrey L. Probstfield Line = papers co-authored together Jeffrey L. Probstfield links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension Peter J. Leary,Samuel G. Rayner,Kelley R. Branch,Laurie Hogl,Nancy M Liston,Lia M. Barros,Jeremy Prout,Stephanie Nolley,Jonathan Buber,David Ralph,Jeffrey L. Probstfield	2025	0
2	Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes Emil Wolsk,Brian Claggett,Rafael Díaz,Kenneth Dickstein,Hertzel C. Gerstein,Lars Køber,Eldrin F. Lewis,Aldo P. Maggioni,John J.V. McMurray,Jeffrey L. Probstfield,Matthew C. Riddle,Scott D. Solomon,Jean‐Claude Tardif,Marc A. Pfeffer	2022	3
3	A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes Hertzel C. Gerstein,Chinthanie Ramasundarahettige,Alvero Avezum,Jan Basile,Ignacio Conget,William C. Cushman,Gilles R. Dagenais,Edward Franek,Mark Lakshmanan,Fernando Laņas,Lawrence A. Leiter,Nana Pogosova,Jeffrey L. Probstfield,Peter Raubenheimer,Matthew C. Riddle,Jonathan E. Shaw,Wayne Huey‐Herng Sheu,Theodora Temelkova‐Kurktschiev,Ibrahim Turfanda,Denis Xavier	2022	10
4	Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease Gilles R. Dagenais,Leanne Dyal,Jackie Bosch,Darryl P. Leong,Victor Aboyans,Scott D. Berkowitz,Deepak L. Bhatt,Stuart J. Connolly,Keith A.A. Fox,Eva Muehlhofer,Jeffrey L. Probstfield,Petr Widimský,Bernhard R. Winkelmann,Salim Yusuf,John W. Eikelboom	2021	4
5	Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT Linda B. Piller,Lara M. Simpson,Sarah Baraniuk,Gabriel B. Habib,Mahboob Rahman,Jan Basile,Richard A. Dart,Allan Ellsworth,Herbert F. Fendley,Jeffrey L. Probstfield,Paul K. Whelton,Barry R. Davis	2014	24
6	Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention Mahshid Dehghan,Andrew Mente,Koon Teo,Peggy Gao,Peter Sleight,Gilles R. Dagenais,Álvaro Avezum,Jeffrey L. Probstfield,Tony Dans,Salim Yusuf	2012	122
7	Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both Michael Böhm,Magnus Baumhäkel,Koon Teo,Peter Sleight,Jeffrey L. Probstfield,Peggy Gao,Johannes F.E. Mann,Rafael Díaz,Gilles R. Dagenais,Garry Jennings,Lisheng Liu,Petr Janský,Salim Yusuf	2010	132
8	NIH consensus development conference draft statement on vaginal birth after cesarean: new insights. F. Gary Cunningham,Shrikant I. Bangdiwala,Sarah Brown,Thomas M. Dean,Marilynn C. Frederiksen,Carol J. Hogue,Tekoa L. King,Emily S. Lukacz,Laurence B. McCullough,Wanda K. Nicholson,Nancy Frances Petit,Jeffrey L. Probstfield,Adele C. Viguera,Cynthia A. Wong,Sheila Cohen Zimmet	2010	49
9	Relationship between coronary artery and descending thoracic aortic calcification as detected by computed tomography: The Multi-Ethnic Study of Atherosclerosis Junichiro Takasu,Matthew J. Budoff,Kevin D. O’Brien,David M. Shavelle,Jeffrey L. Probstfield,J. Jeffrey Carr,Ronit Katz	2008	55
10	Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients Monica Gianni,Jackie Bosch,Janice Pogue,Jeffrey L. Probstfield,Gilles R. Dagenais,Salim Yusuf,Eva Lonn	2007	25
11	Kidney Function and Aortic Valve and Mitral Annular Calcification in the Multi-Ethnic Study of Atherosclerosis (MESA) Joachim H. Ix,Michael G. Shlipak,Ronit Katz,Matthew J. Budoff,David M. Shavelle,Jeffrey L. Probstfield,Junichiro Takasu,Robert Detrano,Kevin D. O’Brien	2007	81
12	Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM Eldrin F. Lewis,Gervasio A. Lamas,Eileen O’Meara,Christopher B. Granger,Mark E. Dunlap,Robert S. McKelvie,Jeffrey L. Probstfield,James B. Young,Eric L. Michelson,Katarina Halling,Jonas Carlsson,Bertil Olofsson,John J.V. McMurray,Salim Yusuf,Karl Swedberg,Marc A. Pfeffer,(unknown)	2006	179
13	Patient Perception of the Effect of Treatment with Candesartan in Heart Failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Eileen O’Meara,Eldrin F. Lewis,C. B. Granger,Mark E. Dunlap,Robert S. McKelvie,Jeffrey L. Probstfield,James B. Young,Eric L. Michelson,Jan Östergren,Jonas Carlsson,Bertil Olofsson,John J.V. McMurray,Salim Yusuf,Karl Swedberg,Marc A. Pfeffer	2005	21
14	Angiotensin-Converting Enzyme Inhibitors and Change in Aortic Valve Calcium Kevin D. O’Brien,Jeffrey L. Probstfield,Michael T. Caulfield,Khurram Nasir,Junichiro Takasu,David M. Shavelle,Audrey H. Wu,Xue-Qiao Zhao,Matthew J. Budoff	2005	130
15	The combination oral and nutritional treatment of late‐onset diabetes mellitus (CONTROL DM) trial results D. M. Reboussin,David C. Goff,Edward W. Lipkin,David M. Herrington,John H. Summerson,Michael W. Steffes,rd JR Crouse,Lois Jovanovič,Mark N. Feinglos,Jeffrey L. Probstfield,Mary Ann Banerji,David J. Pettitt,Jeff D. Williamson	2004	16
16	Beneficial effects of ramipril on cardiovascular events in high-risk patients older than 75 years of age: Secondary outcomes from the HOPE trial Jackie Bosch,Jeffrey L. Probstfield	2003	2
17	Effect of long-term therapy with ramipril in high-risk women Eva Lonn,Rosa Roccaforte,Qilong Yi,Gilles R. Dagenais,Peter Sleight,Jackie Bosch,Pamela S. Suhan,Mary Micks,Jeffrey L. Probstfield,Victoria Bernstein,Salim Yusuf	2002	41
18	Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)breakdown → William C. Cushman,Charles E. Ford,Jeffrey A. Cutler,Karen L. Margolis,Barry R. Davis,Richard H. Grimm,Henry R. Black,Bruce P. Hamilton,Joanne Holland,Chuke Nwachuku,Vasilios Papademetriou,Jeffrey L. Probstfield,Jackson I. Wright,Michael H. Alderman,Robert Weiss,Linda B. Piller,Judy Bettencourt,Sandra Walsh	2002	742
19	Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: The randomized evaluation of strategies for left ventricular dysfunction pilot study Michel White,Salim Yusuf,Robert S. McKelvie,D. Pericak,James B. Young,Roberto Latini,Janice Pogue,Robert J. Burns,Jeffrey L. Probstfield,Ross T. Tsuyuki,Aldo P. Maggioni,Álvaro Avezum,Jean-Lucien Rouleau	2000	146
20	Neurohumoral variability in left ventricular dysfunction Philip C. Kirlin,Claude R. Benedict,Brent J. Shelton,Gary S. Francis,John M. Nicklas,Chang‐seng Liang,Spencer H. Kubo,David E. Johnstone,Jeffrey L. Probstfield,Salim Yusuf	1995	8

About Jeffrey L. Probstfield

Jeffrey L. Probstfield is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Family Practice, having authored 148 papers that have together received 12.2k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (37 papers), Lipoproteins and Cardiovascular Health (23 papers), Heart Failure Treatment and Management (23 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers), Cardiovascular Function and Risk Factors (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Diabetes Treatment and Management (13 papers) and Cardiac Imaging and Diagnostics (12 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.6k citations), Endocrinology, Diabetes and Metabolism (4.4k citations) and Surgery (3.3k citations). Jeffrey L. Probstfield has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Salim Yusuf, David J. Gordon, J. D. Knoke, Herman A. Tyroler, Shrikant I. Bangdiwala, William P. Castelli, James D. Neaton, David R. Jacobs, Robert J. Garrison and Kevin D. O’Brien.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact